Robert J. DeVita

Affiliations: 
Pharmacology Icahn School of Medicine at Mount Sinai, New York, NY, United States 
Google:
"Robert DeVita"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Leandro J, Khamrui S, Suebsuwong C, et al. (2022) Characterization and structure of the human lysine-2-oxoglutarate reductase domain, a novel therapeutic target for treatment of glutaric aciduria type 1. Open Biology. 12: 220179
Wang P, Karakose E, Choleva L, et al. (2021) Human Beta Cell Regenerative Drug Therapy for Diabetes: Past Achievements and Future Challenges. Frontiers in Endocrinology. 12: 671946
He Z, Chen L, Catalan-Dibene J, et al. (2021) Food colorants metabolized by commensal bacteria promote colitis in mice with dysregulated expression of interleukin-23. Cell Metabolism
Kumar K, Suebsuwong C, Wang P, et al. (2021) DYRK1A Inhibitors as Potential Therapeutics for β-Cell Regeneration for Diabetes. Journal of Medicinal Chemistry
Wu K, Huynh KQ, Lu I, et al. (2021) Inhibitors of cullin-RING E3 ubiquitin ligase 4 with antitumor potential. Proceedings of the National Academy of Sciences of the United States of America. 118
Leandro J, Khamrui S, Wang H, et al. (2020) Inhibition and Crystal Structure of the Human DHTKD1-Thiamin Diphosphate Complex. Acs Chemical Biology
Kumar K, Wang P, A Swartz E, et al. (2020) Structure-Activity Relationships and Biological Evaluation of 7-Substituted Harmine Analogs for Human β-Cell Proliferation. Molecules (Basel, Switzerland). 25
Leandro J, Dodatko T, Aten J, et al. (2020) DHTKD1 and OGDH display substrate overlap in cultured cells and form a hybrid 2-oxo acid dehydrogenase complex in vivo. Human Molecular Genetics
Ackeifi C, Wang P, Karakose E, et al. (2020) GLP-1 receptor agonists synergize with DYRK1A inhibitors to potentiate functional human β cell regeneration. Science Translational Medicine. 12
Kumar K, Wang P, Wilson J, et al. (2020) Synthesis and Biological Validation of a Harmine-based, Central Nervous System (CNS)-Avoidant, Selective, Human β-Cell Regenerative Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase A (DYRK1A) Inhibitor. Journal of Medicinal Chemistry
See more...